Using an ACLF mouse model combining chronic liver injury, acute hepatic insult, and bacterial infection that phenocopies some of the key clinical features of ACLF patients [28], we tested the MSC-protective effects of Nrf2/DKK1 co-stimulation (Figure 5A). This evidence concerns the gene NFE2L2 and bacterial infectious disease.